COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $16,021,000 | -39.3% | 1,667,123 | -54.3% | 0.46% | -43.8% |
Q2 2022 | $26,393,000 | -56.5% | 3,645,471 | -22.4% | 0.83% | -31.9% |
Q1 2022 | $60,623,000 | -64.9% | 4,695,848 | -56.6% | 1.21% | -8.8% |
Q4 2021 | $172,616,000 | +124.7% | 10,815,596 | +126.3% | 1.33% | +19.3% |
Q3 2021 | $76,805,000 | -40.9% | 4,779,387 | -49.1% | 1.12% | +32.2% |
Q2 2021 | $129,936,000 | +89.3% | 9,395,224 | +100.0% | 0.84% | -2.8% |
Q1 2021 | $68,632,000 | -15.5% | 4,697,612 | +0.6% | 0.87% | -0.3% |
Q4 2020 | $81,197,000 | +21.7% | 4,671,836 | +28.5% | 0.87% | -10.6% |
Q3 2020 | $66,693,000 | +584.8% | 3,636,485 | +566.9% | 0.97% | +516.5% |
Q2 2020 | $9,739,000 | +30.3% | 545,285 | +110.8% | 0.16% | -64.9% |
Q2 2015 | $7,477,000 | +186.7% | 258,716 | +203.3% | 0.45% | +121.7% |
Q1 2015 | $2,608,000 | -63.5% | 85,288 | -80.5% | 0.20% | -66.1% |
Q4 2014 | $7,148,000 | – | 438,000 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |